Soluble tumour necrosis factor (TNF)-receptor levels in serum as markers of anti-viral host reactivity
about
Immune markers measured before treatment predict outcome of intensive phase tuberculosis therapyA shift to a peripheral Th2-type cytokine pattern during the carcinogenesis of cervical cancer becomes manifest in CIN III lesionsSerum biomarkers of treatment response within a randomized clinical trial for pulmonary tuberculosis.Tumor Necrosis Factor-Mediated Survival of CD169+ Cells Promotes Immune Activation during Vesicular Stomatitis Virus Infection.Tuberculosis (TB) and HIV infection are independently associated with elevated serum concentrations of tumour necrosis factor receptor type 1 and beta2-microglobulin, respectively.
P2860
Soluble tumour necrosis factor (TNF)-receptor levels in serum as markers of anti-viral host reactivity
description
im Mai 1999 veröffentlichter wissenschaftlicher Artikel
@de
scientific article published on 01 May 1999
@en
wetenschappelijk artikel
@nl
наукова стаття, опублікована в травні 1999
@uk
name
Soluble tumour necrosis factor ...... of anti-viral host reactivity
@en
Soluble tumour necrosis factor
@nl
type
label
Soluble tumour necrosis factor ...... of anti-viral host reactivity
@en
Soluble tumour necrosis factor
@nl
prefLabel
Soluble tumour necrosis factor ...... of anti-viral host reactivity
@en
Soluble tumour necrosis factor
@nl
P2093
P2860
P1476
Soluble tumour necrosis factor ...... of anti-viral host reactivity
@en
P2093
P2860
P304
P356
10.1046/J.1365-2249.1999.00903.X
P407
P577
1999-05-01T00:00:00Z